Dyskinesia Matters: But Not as Much as It Used to

This publication has 10 references indexed in Scilit:

• Dyskinesia Matters
  Movement Disorders, 2019
• Parkinson's disease‐associated dyskinesia in countries with low access to levodopa‐sparing regimens
  Movement Disorders, 2019
• Can therapeutic strategies prevent and manage dyskinesia in Parkinson’s disease? An update
  Expert Opinion on Drug Safety, 2019
• Should there be less emphasis on levodopa‐induced dyskinesia in Parkinson's disease?
  Movement Disorders, 2019
• Impact of dyskinesia on activities of daily living in Parkinson's disease: Results from pooled phase 3 ADS-5102 clinical trials
  Parkinsonism & Related Disorders, 2019
• ‘Levodopa Phobia’: a review of a not uncommon and consequential phenomenon
  npj Parkinson's Disease, 2018
• Viewpoint: Developing drugs for levodopa‐induced dyskinesia in PD: Lessons learnt, what does the future hold?
  European Journal of Neuroscience, 2018
• Medical and surgical management of advanced Parkinson's disease
  Movement Disorders, 2018
• The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort
  Movement Disorders, 2016
• The Brazilian health system: history, advances, and challenges
  The Lancet, 2011